• Globe Newswire

Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France

Globenewswire -

• Globe Newswire

Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe

• Globe Newswire

Sandoz reports first quarter 2024 sales

• Globe Newswire

Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG

• Globe Newswire

Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars

• Globe Newswire

Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening immunology offering

• Globe Newswire

Sandoz opens new antibiotic production facility in Austria, to significantly increase capacity for life-saving medicines